Status:
COMPLETED
Virtual Reality Exercise on COPD Patient
Lead Sponsor:
Riphah International University
Conditions:
COPD
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
The program allows the patient to interact with the simulated VR technology using motion sensors, focusing on patients' fitness through various tests providing them a clinically stable environment; to...
Detailed Description
Chronic obstructive lung disease (COPD) is a reversible lung disease which is a principal cause of morbidity and mortality worldwide. It is the third leading cause of death worldwide according to the ...
Eligibility Criteria
Inclusion
- Age:50-70 years
- Both genders
- Clinical Signs and Symptoms of Moderate COPD (GOLD Criteria)
- Clinically Stable
- Ratio of FEV1/ FVC is \<0.7
- Reported Smoking History
Exclusion
- Pneumonia, tuberculosis, and other respiratory
- inflammatory disease
- Heart Failure
- Advanced Uncontrolled Hypertension
- Post Cardiac or Thoracic Surgery (\< 6 Months)
- Neuromuscular Disorders
- Metal Implant in Lower Limb
- Cardiac Pacemaker
- Cognitive Dysfunction or Mini-Mental Scale Scores \<24
- Long- term Non-Invasive Ventilation
- Comorbidity that could Limit Exercise Testing and Training i.e., Arthritis, Osteoporosis, Fracture, Diabetic Neuropathy etc.
Key Trial Info
Start Date :
October 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05234827
Start Date
October 16 2020
End Date
August 31 2021
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Mustafa Trust Medical Center
Rawalpindi, Punjab Province, Pakistan